findmyKOL
Clinical trialNCT00601640CompletedPhase 2Interventional

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

SponsorUniversity of ArizonaEnrollment184Other Benign Neoplasm of Skin, Unspecified
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of eflornithine and diclofenac may stop cancer from growing in patients with sun-damaged skin. PURPOSE: This randomized phase II trial is studying the side effects and how well eflornithine works compared with diclofenac, given alone or together, in treating patients with sun-damaged skin.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center

    Tucson, Arizona, United States

  • Veterans Affairs Medical Center - Tucson

    Tucson, Arizona, United States

  • Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea

    Tucson, Arizona, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Diclofenac Na gelEflornithine HCL ointment
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2007
Primary completion
28 Feb 2010
Completion
31 Dec 2014
Last update posted
23 Mar 2017
Registered enrollment
184
Registry id
NCT00601640
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.